Prevalence and pathogenicity of anti-SPCA1 and anti-M3AchR autoantibodies in pemphigus
British Journal of Dermatology · 19.05.2026 · 194 (6) · 1182-1184
DOI: 10.1093/bjd/ljag093 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Dermatology, online erschienen am 10.03.2026. Verfasst von Billal Tedbirt und 9 weiteren Autor:innen. Beteiligte Einrichtung: University of Rouen Normandie, Inserm, Normandie University, PANTHER UMR 1234, CHU Rouen, Department of Dermatology, Rouen, France. Die Arbeit nennt 8 Literaturangaben. Gefördert von: Rouen University Hospital.
Abstract (Originalsprache)
Anti-muscarinic-acetylcholine-receptor-subtype-M3 (anti-M3AchR) and anti-secretory-pathway-Ca2+/Mn2+-ATPase-isoform-1 (anti-SPCA1) autoantibodies have been suggested as potential targets in pemphigus. However, their role during the course of pemphigus remains poorly characterized. The objective of the study was to determine the frequency, evolution and pathogenicity of anti-SPCA1 and anti-M3AchR autoantibodies in pemphigus. Anti-SPCA1 and anti-M3AchR IgG were detected in almost one-third of sera from patients with pemphigus. We demonstrated their in vitro pathogenic activity, alone or in combination. Anti-SPCA1 and anti-M3AchR autoantibodies were associated with a higher risk of relapse and may help clinicians in patient management.
Autor:innen und Institutionen
- University of Rouen Normandie, Inserm, Normandie University, PANTHER UMR 1234, CHU Rouen, Department of Dermatology, Rouen, France.
- University of Rouen Normandie, Normandie University, PRIMACEN, Rouen, France.
- University of Rouen Normandie, Inserm, Normandie University, PANTHER UMR 1234, Rouen, France.
- University of Rouen Normandie, Inserm, Normandie University, PANTHER UMR 1234, CHU Rouen, Department of Immunology and Biotherapy, Rouen, France.
ORCID-Profile: Billal Tedbirt, Alexandre Lemieux, Maud Maho-Vaillant, Damien Schapman, Leopoldine Lebourgeois, Vivien Hébert, Olivier Boyer, Sébastien Calbo, Pascal Joly, Marie-Laure Golinski
Förderung
- Rouen University Hospital
Zitieren
APA
Tedbirt, B., Lemieux, A., Maho-Vaillant, M., Schapman, D., Lebourgeois, L., Hébert, V., Boyer, O., Calbo, S., Joly, P., & Golinski, M. L. (2026). Prevalence and pathogenicity of anti-SPCA1 and anti-M3AchR autoantibodies in pemphigus. British Journal of Dermatology, 194(6), 1182-1184. https://doi.org/10.1093/bjd/ljag093
Vancouver
Tedbirt B, Lemieux A, Maho-Vaillant M, Schapman D, Lebourgeois L, Hébert V, et al. Prevalence and pathogenicity of anti-SPCA1 and anti-M3AchR autoantibodies in pemphigus. British Journal of Dermatology. 2026;194(6):1182-1184. doi:10.1093/bjd/ljag093
BibTeX
@article{Tedbirt2026,
author = {Tedbirt, Billal and Lemieux, Alexandre and Maho-Vaillant, Maud and Schapman, Damien and Lebourgeois, Leopoldine and Hébert, Vivien and Boyer, Olivier and Calbo, Sébastien and Joly, Pascal and Golinski, Marie-Laure},
title = {Prevalence and pathogenicity of anti-SPCA1 and anti-M3AchR autoantibodies in pemphigus},
journal = {British Journal of Dermatology},
year = {2026},
volume = {194},
number = {6},
pages = {1182--1184},
doi = {10.1093/bjd/ljag093}
}
EUVIMED